Page 283 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 9 of 10 Original Research

of the routine programme coupled with targeted interventions 9. National Department of Health of South Africa. National consolidated guidelines
will ensure continued improvements in the outcomes of for the prevention of mother-to-child transmission of HIV (PMTCT) and the
management of HIV in children, adolescents and adults. Pretoria: NDoH;
these high-risk individuals. December 2014.
10. South African Government. Statement on the meeting of the South African
National AIDS Council [homepage on the Internet]. 2011 [cited 2018 Oct 10].
Acknowledgement Available from: https://www.gov.za/statement-meeting-south-african-national-
aids-council-sanac.
11. National Department of Health of South Africa. HIV & AIDS and STI strategic plan
Competing interest for South Africa 2007–2011. Pretoria: NDoH; 2007.
12. Osler M, Hilderbrand K, Hennessey C, et al. A three-tier framework for monitoring
The authors have declared that no competing interests exist. antiretroviral therapy in high HIV burden settings. J Int AIDS Soc. 2014;17:18908.
https://doi.org/10.7448/IAS.17.1.18908
13. Meintjes G, Kerkhoff AD, Burton R, et al. HIV-related medical admissions to a
Author contributions South African district hospital remain frequent despite effective antiretroviral
therapy scale-up. Medicine (Baltimore). 2015;94(50):e2269. https://doi.org/
R.R.L., K.R. and R.P.H.P. conducted the data analysis. M.M., 10.1097/MD.0000000000002269
H.E.S. and J.A.M. supported the data collection process. 14. World Health Organization. South Africa - HIV country profile: 2017 [homepage on
the Internet]. 2019 [cited 2019 Jan 15]. Available from: http://cfs.hivci.org/
R.R.L. wrote the manuscript. All authors provided in-depth country-factsheet.html.
comments and input on all versions of the manuscript and 15. Lewden C, Drabo YJ, Zannou DM, et al. Disease patterns and causes of death of
hospitalized HIV-positive adults in West Africa: A multicountry survey in the
approved the final version. antiretroviral treatment era. J Int AIDS Soc. 2014;17(1):18797. https://doi.
org/10.7448/IAS.17.1.18797
16. Nsanzimana S, Remera E, Kanters S, et al. Life expectancy among HIV-positive
Data availability statement patients in Rwanda: A retrospective observational cohort study. Lancet Glob
Health. 2015;3(3):e169–177. https://doi.org/10.1016/S2214-109X(14)70364-X
Data are available from the corresponding author upon 17. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving
combination antiretroviral therapy in low-income countries: A cohort analysis
request. from Uganda. Ann Intern Med. 2011;155(4):209–216. https://doi.org/10.7326/
0003-4819-155-4-201108160-00358
18. Luma HN, Jua P, Donfack OT, et al. Late presentation to HIV/AIDS care at the
Funding Douala general hospital, Cameroon: Its associated factors, and consequences.
BMC Infect Dis. 2018;18(1):298. https://doi.org/10.1186/s12879-018-3204-8
This study is made possible by the generous support of the 19. McCreesh N, Andrianakis I, Nsubuga RN, et al. Improving ART programme
retention and viral suppression are key to maximising impact of treatment as
American people through the US President’s Emergency Plan prevention: A modelling study. BMC Infect Dis. 2017;17(1):557. https://doi.
for AIDS Relief (PEPFAR) through the United States Agency org/10.1186/s12879-017-2664-6
for International Development (USAID) under Cooperative 20. Rozhnova G, Anastasaki M, Kretzschmar M. Modelling the dynamics of population
viral load measures under HIV treatment as prevention. Infect Dis Model.
Agreement number AID-674-A-12-00015, entitled ‘Systems 2018;3:160–170. https://doi.org/10.1016/j.idm.2018.09.001
Strengthening for Better HIV/TB Patient Outcomes’, and 21. Massyn N, Padarath A, Peer N, Day C, editors. District Health Barometer 2016/17.
Durban: Health Systems Trust; 2017.
Cooperative Agreement number 72067418CA00023 for the 22. National Department of Health of South Africa. National antenatal sentinel HIV &
Accelerating Program Achievements to Control the Epidemic syphilis survey report 2015. Pretoria: NDoH; 2017.
(APACE) Activity in South Africa to the Anova Health Institute. 23. StataCorp LLC. sts test - test equality of survivor functions [homepage on the
Internet]. 2018 [cited 2018 Oct 11]. Available from: https://www.stata.com/
manuals13/stststest.pdf.
24. Auld AF, Shiraishi RW, Oboho I, et al. Trends in prevalence of advanced HIV disease
Disclaimer at antiretroviral therapy enrollment – 10 countries, 2004-2015. MMWR Morb
Mortal Wkly Rep. 2017;66(21):558–563. https://doi.org/10.15585/mmwr.
The contents presented in this article are the responsibility of mm6621a3
Anova Health Institute and do not necessarily reflect the 25. IeDEA and ART Cohort Collaborations, Avila D, Althoff KN, et al. Immunodeficiency
at the start of combination antiretroviral therapy in low-, middle-, and high-
views of USAID or the United States Government. The income countries. J Acquir Immune Defic Syndr. 2014;65(1):e8–16. https://doi.
org/10.1097/QAI.0b013e3182a39979
funders had no role in the study design, data collection and 26. Katz IT, Kaplan R, Fitzmaurice G, et al. Treatment guidelines and early loss from
analysis, decision to publish or preparation of the manuscript. care for people living with HIV in Cape Town, South Africa: A retrospective cohort
study. PLoS Med. 2017;14(11):e1002434. https://doi.org/10.1371/journal.
pmed.1002434
References 27. Carmona S, Bor J, Nattey C, et al. Persistent high burden of advanced HIV disease
among patients seeking care in South Africa’s national HIV program: Data from a
1. Joint United Nations Programme on HIV/AIDS. Country: South Africa [homepage nationwide laboratory cohort. Clin Infect Dis. 2018;66(suppl_2):S111–S117.
https://doi.org/10.1093/cid/ciy045
on the Internet]. c2018 [cited 2018 Oct 10]. Available from: http://www.unaids.
org/en/regionscountries/countries/southafrica/. 28. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell
2. Cornell M, Johnson LF, Wood R, et al. Twelve-year mortality in adults initiating count and viral load after initiating triple-drug therapy. JAMA. 2001;286(20):
2568–2577. https://doi.org/10.1001/jama.286.20.2568
antiretroviral therapy in South Africa. J Int AIDS Soc. 2017;20(1):21902. https://
doi.org/10.7448/IAS.20.1.21902 29. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults
accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS.
3. Johnson LF, Mossong J, Dorrington RE, et al. Life expectancies of South African 2008;22(15):1897–1908. https://doi.org/10.1097/QAD.0b013e32830007cd
adults starting antiretroviral treatment: Collaborative analysis of cohort studies.
PLoS Med. 2013;10(4):e1001418. https://doi.org/10.1371/journal.pmed.1001418 30. Statistics South Africa. Mortality and causes of death in South Africa, 2016:
Findings from death notification. Pretoria: StatsSA; 2018.
4. United Nations. Resolution adopted by the General Assembly on 25 September
2015 – 70/1. Transforming our world: The 2030 agenda for sustainable 31. Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in
development. New York: UN; 2015. rural South Africa: Valuing the scale-up of HIV treatment. Science.
2013;339(6122):961–965. https://doi.org/10.1126/science.1230413
5. National Department of Health of South Africa. National antiretroviral treatment
guidelines. Pretoria: NDoH; 2004. 32. Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs
stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized
6. National Department of Health of South Africa. Clinical guidelines for the trial. JAMA. 2004;292(2):191–201. https://doi.org/10.1001/jama.292.2.191
management of HIV & AIDS in adults and adolescents. Pretoria: NDoH; 2010. 33. Airoldi M, Zaccarelli M, Bisi L, et al. One-pill once-a-day HAART: A simplification
7. National Department of Health of South Africa. The South African antiretroviral strategy that improves adherence and quality of life of HIV-infected subjects.
treatment guidelines. Pretoria: NDoH; 2013. Patient Prefer Adherence. 2010;4:115–125. https://doi.org/10.2147/PPA.S10330
8. National Department of Health of South Africa. Implementation of the universal 34. Llibre JM, Arribas JR, Domingo P, et al. Clinical implications of fixed-dose
test and treat strategy for HIV positive patients and differentiated care for stable coformulations of antiretrovirals on the outcome of HIV-1 therapy. AIDS.
patients (circular). Pretoria: NDoH; 2016. 2011;25(14):1683–1690. https://doi.org/10.1097/QAD.0b013e3283499cd9
http://www.sajhivmed.org.za 276 Open Access